Novotech

News

Kraig Biocraft laboratories expands domestic dragon silktm production capacity with new texas location

Kraig Biocraft Laboratories , the leading developer of spider silk based fibers announced it had secured a long term property lease in Texas for the Companyโ€™s domestic mulberry production. Over the next 60 days the Company...

Fresenius Medical Care Announces Leadership Change in North America

Fresenius Medical Care, the worldโ€™s largest provider of dialysis products and services, today announced a leadership change in North America. William (Bill) Valle (56) has been appointed the new Chief Executive Officer (CEO) of North America,...

Alexion Says FDA Grants Orphan Drug Designation To ALXN1210

Alexion Pharmaceuticals Inc announced that the U.S. FDA has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting anti-C5 antibody that inhibits terminal complement, which is being evaluated for the treatment of patients with paroxysmal nocturnal hemoglobinuria...

ย Hologics Aptima HIV-1 Quant assay gets PMA approval from FDA

Hologic, Inc announced that the U.S. FDA has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptimaยฎ HIV-1 Quant assay is a nucleic acid amplification test for the quantitative detection of RNA from HIV in...

Sanofi Pasteur and MSD end joint vaccines business in Europe

Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Pasteur MSD (SPMSD). Sanofi...

OSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7

OSE Immunotherapeutics SA announced that the company has entered into a worldwide license option agreement with Servier, an independent international pharmaceutical company, for the development and commercialization of OSE Immunotherapeuticsโ€™ Effi-7, an antagonist of the interleukin-7 receptor. ...

Saneca Pharma Expands R&D Capabilities

Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a โ‚ฌ1.5 million grant from the Slovak Ministry of Education, Science, Research and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป